One More Chinese COVID-19 Vaccine Enters Late-Stage Human Trials

One More Chinese COVID-19 Vaccine Enters Late-Stage Human Trials Hits: 63 – 20/11/20 20:45 Hits: 63

HEFEI, Nov. 20 (Xinhua) — Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced phase-3 clinical trials for its COVID-19 vaccine, planning to recruit 29,000 volunteers across the world.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Visit the original:
ChinaPulse.com

Comments are closed.